Abstract Adrenal adenomas usually show 18 F-FDG activity less than that of the liver parenchyma. However, lipid-poor and hormone-secreting adenomas have been reported to show mild 18 F-FDG avidity. We report on a 51-year-old female with clinical symptoms of hypercortisolemia and a large right adrenal mass detected on CT. Post-contrast CT images showed an enhancing focus in the lower pole of the mass, with corresponding markedly increased activity on 18 F-FDG PET/CT. Right adrenalectomy was performed and histology revealed a benign adenoma, indicating that functioning benign adenomas can show intensely increased metabolic activity on 18 F-FDG mimicking malignancy.
A 51-year-old female was found to have an adrenal mass during the investigation for sudden onset of upper abdominal pain. For 3 years, the patient had been experiencing generalized weakness, worsening headaches, hypertension, weight gain, hot flashes, and generalized hair loss. Subsequent biochemical work-up revealed ACTHindependent hypercortisolemia, while the corresponding ACTH levels were less than 5 pg/ml both times. Further, biochemical work-up including plasma levels of catecholamines, aldosterone, and renin ruled out both pheochromocytoma and primary hyperaldosteronism. The patient underwent CT scan of the adrenals with contrast which showed a 5.2-cm right adrenal mass (Fig. 1a , b yellow crosses; coronal and axial post-contrast CT images). On the post-contrast images, there was an enhancing focus (107 mean H.U.) in the lower pole of the mass raising the suspicion of malignancy (Fig. 1a, b : yellow arrows). The patient underwent PET/CT using 18 F-FDG (glucose analogue) in order to evaluate the metabolic activity of the adrenal mass. The main bulk of the tumor showed less uptake (SUVmax: 3.49) compared to the liver (SUVmax: 4.52), whereas the enhancing focus in the lower pole showed increased 18 F-FDG activity (SUVmax: 8.6) (Fig. 1c, d : white arrows; coronal and axial fused PET/CT images). Given the size of the adrenal mass and the increased 18 F-FDG uptake by its lower part, decision for right adrenalectomy was made in order to rule out adrenocortical carcinoma (ACC).
Macroscopic examination of the resected right adrenal gland showed a 5-cm cortical mass (Fig. 1e) , while bisection revealed a distinct 0.9 cm nodule ( Fig. 1e;  arrows) . On microscopic examination, the tumor outside the smaller nodule showed uniform cells with foamy cytoplasm and small round nuclei ( Fig. 1f; H&E, 4009) , while areas of myelolipomatous change were also identified ( Fig. 1g; H&E, 2009 ). Blood lakes, as well as cystic degeneration, hemorrhage, and calcifications were seen, while no necrotic areas were detected. Microscopic examination of the smaller nodule ( Fig. 1e; more nuclear pleomorphism than was seen in the rest of the tumor ( Fig. 1h; H&E, 2009 ). However, neither of the two regions of the mass presented changes such as true necrosis, vascular invasion, or high mitotic rate that would suggest malignancy. Adrenal adenomas typically do not show increased 18 F-FDG activity, although lipid-poor and functioning adenomas have been reported to show mild 18 F-FDG avidity [1, 2] . Setting a specific SUV threshold in order to differentiate adenomas from malignant adrenal tumors can be misleading. Therefore, comparison to average 18 F-FDG uptake by the liver is considered a more efficient approach to assess hypermetabolic adrenal tumors [3] . The presented case indicates that adrenal lesions with 18 F-FDG activity markedly higher than the liver uptake should be considered cautiously, since although they are more likely to be malignant, they may prove to be benign adenomas. 
